Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: biological samples analysis.
- Who it may be relevant to
- Registry conditions: Carotid Artery Stenosis, Glioma, Intracranial Aneurysm, Intracranial Hemorrhages. Basic parameters: 18 years — 80 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Presence of Microplastics and Nanoplastics in Neurosurgery Patients
Overview
Plastic particles are a ubiquitous pollutant in the living environment and food chain, so far, plenty of studies have reported the internal exposure of microplastics and nanoplastics in human tissues and enclosed body fluids. Neurosurgery is the only department that can open the skull. In addition to blood and cerebrospinal fluid, there are brain tissue and tumors in the presence of lesions. Whether any of these microplastics and nanoplastics are present remains a mystery. This prospective observational study will harvest biological samples of neurosurgery patients. The objective of this research is to be able to detect microplastics and nanoplastics on blood and operation samples of neurosurgery patients.
Interventions
- Diagnostic test biological samples analysis
biological samples analysis
Primary outcome measures
- microplastics [Time frame: baseline, intraoperative]
- nanoplastics [Time frame: baseline, intraoperative]
Eligibility criteria
Inclusion criteria
- Age 18-80 years
- Any type of neurosurgery
Exclusion criteria
·refusal of the patient to participate
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- Beijing Tiantan Hospital, Capital Medical University — Beijing
Identifiers
NCT: NCT05968053 · DT-MiNi